Letermovir

Kathryn Dzintars, Pharm.D., BCPS
Letermovir is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Prophlyaxis of cytomegalovirus infection (CMV) in patients (> 18 years of age) who are CMV-seropositive and have undergone an allogeneic stem cell transplant

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 6, 2018